trans-C75

Research use only, not for human use.

trans-C75 is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).

trans-C75 is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN). Treatment with C75 alone decreased clonogenic survival, an effect that was abrogated by the antioxidant. C75 treatment also delayed spheroid growth in a concentration-dependent manner. The radiosensitizing effect of C75 was indicated by combination index values between 0.65 and 0.71 and the reduced surviving fraction of clonogens, in response to 2 Gy X irradiation, from 0.51 to 0.30 and 0.11 in the presence of 25 and 35 μM C75, respectively. This increased sensitivity to radiation was reduced by the presence of the antioxidant. The C75 treatment also enhanced the spheroid growth delay induced by X irradiation in a supra-additive manner. The level of radiation-induced apoptosis in prostate cancer cells was increased further by C75, which induced cell cycle arrest in the G2/M phase, but only at a concentration greater than that required for radiosensitization.

——

——

(±)-C75

Metabolic Enzyme/Protease

Fatty Acid Synthase

FAS

——

——

191282-48-1

254.32

C14H22O4

>98% (HPLC)

DMSO:83.3 mg/mL (327.54 mM; Need ultrasonic and warming)

CCCCCCCC[C@H]1OC(=O)C(=C)[C@@H]1C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years